ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
Nicoletta Colombo(University of Milano-Bicocca), Antonio González-Martı́n(Spanish Ovarian Cancer Research Group), W. Glenn McCluggage(Belfast Health and Social Care Trust), Mojgan Devouassoux‐Shisheboran, Florence Joly(Centre François Baclesse), Frédéric Kridelka(University of Liège), Annamaria Ferrero, Nicole Concin(Medical University of Vienna), A. Dashora(Maidstone and Tunbridge Wells NHS Trust), Paweł Blecharz, Ilan Bruchim(Institut Gustave Roussy), Rosalind Glasspool(Institut Bergonié), Denis Querleu(Agostino Gemelli University Polyclinic), Andreas du Bois(Kliniken Essen-Mitte), Philippe Morice(Inserm), Viola Heinzelmann‐Schwarz(Roche (Switzerland)), I. Belaroussi(Institut Gustave Roussy), Ignace Vergote(KU Leuven), Domenica Lorusso(Agostino Gemelli University Polyclinic), Susana Banerjee(Royal Marsden NHS Foundation Trust), J.W. Kim, Patricia Pautier(Université Paris-Saclay), Shibani Nicum(London Cancer), David Cibula(Charles University), Isabelle Ray‐Coquard(Centre Léon Bérard), Ben Davidson(Oslo University Hospital), Siel Olbrecht(The European Academy of Gynaecological Surgery), Jonathan A. Ledermann(London Cancer), Mansoor Raza Mirza(C4 Therapeutics (United States)), Sandro Pignata(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Cristiana Sessa(Institute of Oncology Research), François Planchamp, Mikio Mikami(Shonan University of Medical Sciences), Iain A. McNeish(Imperial College London), Sven� Mahner(LMU Klinikum), Thaïs Baert(Kliniken Essen-Mitte), Dearbhaile M. O’Donnell
Cited by 1,162
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
|International Journal of Gynecological Cancer|2020|1.9k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k